drugset / Trial / NCT01899430
Polycystic Ovary Syndrome and Liraglutide
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to determine whether liraglutide is more effective than metformin in the treatment of obese women with newly diagnosed polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients treated with liraglutide than in those treated with metformin.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-10
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 1.2 mg | Subcutaneous |
| Comparator | Metformin | Small molecule | 1000 mg | Oral |